iifl-logo

Transgene Biotek Ltd Cash Flow Statement

3.55
(-1.93%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Transgene Biotek FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-10.43

-10.96

-5.65

-19.86

Depreciation

-9.9

-9.89

-9.89

-17.52

Tax paid

0

0

-0.78

0

Working capital

0.23

0.05

-6.9

-1.21

Other operating items

Operating

-20.11

-20.79

-23.22

-38.59

Capital expenditure

0.03

0.03

-0.31

-98.56

Free cash flow

-20.08

-20.76

-23.53

-137.15

Equity raised

-121.34

-90.62

-68.96

64.27

Investing

0.01

0

0

-92.2

Financing

13.4

12.79

15.47

18.61

Dividends paid

0

0

0

0

Net in cash

-128.01

-98.6

-77.03

-146.47

Transgene Biotek : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.